MedPath

A Observational Study to understand the Effectiveness and Tolerability of Azithromycin on Patients with Upper Respiratory Tract Infection.

Not Applicable
Conditions
Health Condition 1: J029- Acute pharyngitis, unspecified
Registration Number
CTRI/2024/04/066497
Lead Sponsor
Alembic Pharmaceuticals Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Adult patients aged more than or equal to 18 years of either gender

2. Patients who had received oral Azithromycin for the management of pharyngitis in the past.

Exclusion Criteria

Patients those who were not suitable to receive Azithromycin tablet in management of Pharyngitis as per the local prescription data

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath